Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria. [PDF]
Etuk VP +3 more
europepmc +1 more source
Structure-Guided Design of Novel Diarylpyrimidine-Based NNRTIs Through a Comprehensive In Silico Approach: 3D-QSAR, ADMET Evaluation, Molecular Docking, and Molecular Dynamics. [PDF]
Baassi M +5 more
europepmc +1 more source
Seasonal analysis and environmental risk assessment of selected emerging pollutants in the Vaal River catchment area of South Africa. [PDF]
Mthiyane ZL +5 more
europepmc +1 more source
Synthesis of novel N1 functionalized diazepinone analogues <i>via</i> a base-mediated C-N cross coupling reaction as reverse transcriptase inhibitors: theoretical and experimental investigations. [PDF]
Jaiswal S +7 more
europepmc +1 more source
ABCB1 Polymorphism in HIV-Infected Individuals Taking Antiretroviral Drugs. [PDF]
Singh H, Samani D, Mahajan SD.
europepmc +1 more source
Comparative Analysis of Effectiveness of Dolutegravir-Based Regimen (TLD) vs. Efavirenz-Based Regimen (TLE) to Prevent Mother-to-Child Transmission of HIV. [PDF]
Kashyap M +4 more
europepmc +1 more source
Viral suppression and adverse events following antiretroviral therapy optimization among children and adolescents in Uganda, 2018-2023. [PDF]
Ankunda C +5 more
europepmc +1 more source
Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc +1 more source
Quality-of-life changes six months after the programmatic switch from nevirapine to dolutegravir-based ART in stable PLWH: a prospective cohort study in Indonesia. [PDF]
Pane MR +6 more
europepmc +1 more source
Virological Remission in Two HIV-Infected Children After Early cART in Libreville, Gabon. [PDF]
Bivigou-Mboumba B +5 more
europepmc +1 more source

